Goldplay Exploration Ltd. (TSXV: GPLY, FRANKFURT: GPE, OTCQB: GLYXF) (“Goldplay” or the “Company”) is pleased to announce that the exploratory program carried out in the December quarter of 2018 at the San Marcial Project, located in the Rosario Mining District, Sinaloa, Mexico, has expanded the Ag-Zn-Pb-Au mineralized trend beyond the historic NI 43-101 resource area (“historic resource”), with five new exploration targets identified.
MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / OTCQB: MGXMF / FSE: 1MG) and engineering partner PurLucid Treatment Solutions (“PurLucid”) are pleased to report commissioning results from its commercial-scale 5m3 per hour (750 barrel per day) NFLi-5 advanced wastewater treatment system. The system is currently operating and under contract with an oilsands SAGD operator to process evaporator blowdown water (EBD). The study focused on a 3-week operational period in December 2018 as preparation for an additional in-line deployment of a new 10m3 per hour (1500 bpd), which is now underway.
At the request of IIROC, the Company wishes to retract and clarify certain disclosure in its January 15, 2019 news release. Specifically, the disclosure “doubling resource potential” is a violation of NI 43-101, 2.3(1)(a) – Restricted Disclosure, as “resource potential” is not a recognized term for Canadian securities legislation, nor can “resource potential” be “doubled” and is therefore misleading. All references to “resource potential” and “doubling resource potential” are retracted. The drill results disclosed in the news release should have been disclosed as exploration results and are accordingly clarified in this release.
Goldplay Exploration Ltd. (TSXV: GPLY, FRANKFURT: GPE OTCQB: GLYXF) (“Goldplay” or the “Company”) is pleased to announce the listing of its shares on the Frankfurt Stock Exchange under the symbol GPE effective January 15, 2019.
MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / FKT: 1MG / OTCQB: MGXMF) is pleased to report that shareholders voted in favor of all resolutions brought forth at the Company’s annual general and special meeting of shareholders (the “Meeting”) held on Friday, January 11, 2019 in Vancouver, British Columbia.
Millennial Lithium Corp. (TSXV: ML) (FSE: A3N2) (OTCQX: MLNLF) (“Millennial” or the “Company”) is pleased to report that bench scale process test work completed by SGS Canada Inc. (SGS) in their facilities in Lakefield, ON on brine from the Company’s Pastos Grandes project in Salta, Argentina, has yielded battery grade (> 99.5% Li2CO3) lithium carbonate. Final purification testwork results yielded a lithium carbonate product that is 99.92% Li2CO3 with low levels of magnesium (Mg), calcium (Ca), boron (B), sulphate (SO4) and iron (Fe), with no other detectable metals.
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company“) and Comstock Metals Ltd. (TSX.V: CSL) (“Comstock” or the “Vendor”) are pleased to announce that they have entered into a binding letter agreement dated January 11, 2019 pursuant to which the Company will purchase from the Vendor the property known as the QV Gold Project (the “Property”) subject to the terms and conditions therein (the “Acquisition”). The Property covers 16,335 hectares (40,000 acres) in the Yukon’s White Gold District, bringing the Company’s total holdings in the White Gold District to 439,000 hectares (1,080,000 acres). The QV Gold Project is contiguous to the Company’s White Gold property which hosts its Golden Saddle and Arc deposits, 20 km southwest of the Company’s Vertigo Discovery on its JP Ross property and 44 kilometres northwest of Goldcorp Inc.’s (TSX: G, NYSE: GG) Coffee project. The Company looks forward to incorporating the Property into its systematic and data driven regional exploration program backed by partners Agnico Eagle Mines Limited (TSX: AEM, NYSE: AEM) and Kinross Gold Corp (TSX: K, NYSE: KGC).
FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) would like to congratulate Cannara Biotech Inc. (“Cannara”) for its listing approval and commencement of trading on the Canadian Securities Exchange (“CSE”) today under the stock symbol “LOVE”. FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares (“Common Shares”) of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer.